8% of the people in a study being between an 11-year age gap is in no way outrageously low, though?Correct.
The rub is this: the data should be there before licensing it. AZ appear to have not tested enough to make this a no brainer for older groups in the same way that Pfizer / Moderna is. It might well be efficacious enough, but until they get the evidence back from ongoing take up, it's an issue.
AZ the roll out started 3 weeks ago yesterday - we’re only just starting to see large scale results from Israel and they’ve been administering Pfizer for much longer?This is the curious thing, the UK have been rolling out the AZ for weeks and likely on a larger scale then the AZ clinical trial, it should be very easy to analyse that data, but there doesn't seem to much either good or bad unless im missing it. I mean that in the same way that Israel have been providing a lot of data on the Pfizer vaccine.
That said there was a significant drop in the number of cases yesterday and if that continues to today, there might be a strong set of data to suggest that vaccine roll out - including AZ is making a significant difference to the UK rate of infection.
surely any certain results we see now will start to be from the Pfizer roll out which started before Xmas in the UK, and then the first doses of AZ?